The Advisory Committee on Immunization Practices recommends the preexposure recombinant vesicular stomatitis virus–Zaire Ebola virus for those 18 years or older who may be exposed to Ebola either because they are responding to an Ebola outbreak, working as healthcare personnel at federally designated Ebola treatment centers in the U.S., or working as laboratorians or other staff at biosafety-level 4 facilities in the U.S.
The vaccine is a one-time treatment approved by the FDA Dec. 19.
More articles on clinical leadership and infection control:
North Carolina university to offer master’s degree in patient safety
Judge changes mind, orders release of Seattle Children’s mold records
Patient charged in stabbing of 3 nurses with scissors at New York hospital
